Alleviant Medical focuses on innovative technologies aimed at addressing heart failure, particularly through its proprietary device designed for the treatment of patients with heart failure with preserved ejection fraction (HFpEF). The company’s flagship product utilizes a unique approach to reduce elevated pressures in the heart and lungs, which can significantly improve patient outcomes. This device is engineered to be minimally invasive, allowing for easier implantation and potentially reducing recovery times compared to traditional surgical methods.

In addition to its primary device, Alleviant Medical is committed to advancing its research and development pipeline, which includes various therapeutic solutions targeting different aspects of heart failure. The company emphasizes a science-driven approach, leveraging insights from clinical studies and patient feedback to refine its technologies. By focusing on both the mechanical and physiological aspects of heart failure, Alleviant Medical aims to provide comprehensive solutions that enhance the quality of life for patients suffering from this condition.

United States

Alleviant Medical is a medical device company developing next-generation therapies for heart failure.

Alleviant Medical

Company Details